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Spontaneous Redistribution After Reperfusion
A Unique Property of AIP 201, an Ultrasound Contrast Agent
ANDRE Z. LINKA, MD, DANNY M. SKYBA, PHD, RICHARD J. PRICE, PHD,*
KEVIN WEI, MD, FACC, THOMAS C. SKALAK, PHD,* SANJIV KAUL, MD, FACC
Charlottesville, Virginia
Objectives. We sought to determine the mechanism of sponta-
neous redistribution of AIP 201 microbubbles after reperfusion
from a single left heart injection performed during coronary
occlusion.
Background. AIP 201, an ultrasound contrast agent consisting
of 10-mm sized microbubbles, has demonstrated spontaneous
myocardial redistribution in preliminary studies.
Methods. Myocardial video intensity (VI) and radiolabeled
microsphere-derived myocardial blood flow (MBF) were mea-
sured serially after reperfusion in seven dogs undergoing an AIP
201 injection during coronary occlusion. The behavior of these
bubbles was also assessed in the rat spinotrapezius muscle using
intravital microscopy (IM), both with and without ultrasound.
The effect of ultrasound on these bubbles was also determined in
vitro.
Results. A spontaneous and gradual increase in myocardial VI
was noted after reperfusion, which was related to the magnitude of
increase in MBF to that region (r 5 0.82, p < 0.001). On IM, most
of the microbubbles were seen entrapped in small arterioles. Some
larger arterioles had aggregates of microbubbles that periodically
became dislodged and moved downstream. This behavior was not
affected in vivo by ultrasound. In vitro, however, microbubble
aggregation was noted only during ultrasound exposure.
Conclusions. The magnitude of redistribution of AIP 201 mi-
crobubbles to the reperfused myocardium is related to changes in
MBF and occurs from their dislodgement from microbubble
aggregates entrapped in large arterioles. In vitro microbubble
aggregation seen during ultrasound exposure was not reproduced
in vivo. These results may have important implications for
studying the effects of interventions in acute coronary syndromes
and after coronary artery bypass graft surgery.
(J Am Coll Cardiol 1998;32:1765–72)
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AIP 201 is an ultrasound contrast agent that consists of
air-filled microbubbles with a mean concentration of 1.5 3
107zml21, a mean diameter of 10 mm and a 1-mm thick shell
composed of denatured albumin. The large size of the micro-
bubbles precludes their intravenous use; however, they provide
excellent myocardial opacification on ultrasound examination
when injected into the aortic root or left heart because they
become entrapped in the myocardial microcirculation. Their
thick shell prevents inward or outward diffusion of air as well
as their destruction by ultrasound (1). These properties result
in long-lasting myocardial opacification on ultrasound exami-
nation (1).
AIP 201 does not cause adverse hemodynamic effects when
injected into the left atrium in doses required to produce
optimal myocardial opacification (1). It can also be used to
accurately define risk area during coronary occlusion and
infarct size after reperfusion (1). In pilot studies we observed
that when it was injected during coronary occlusion, as ex-
pected, a lack of myocardial opacification was noted within the
occluded bed. After reperfusion, however, a spontaneous and
gradual increase in myocardial opacification of the previously
occluded bed was seen, which was not associated with recircu-
lation of the agent as evidenced by the lack of contrast effect in
the cardiac chambers. To our knowledge, this unique phenom-
enon of redistribution has not been reported before with any
other ultrasound contrast agent.
The purposes of this study were to further characterize this
phenomenon of spontaneous redistribution of AIP 201 micro-
bubbles after reperfusion and to elucidate its mechanism. An
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additional aim was to determine whether this phenomenon is
influenced by exposure to ultrasound.
Methods
The experiments were approved by the Animal Research
Committee at the University of Virginia and conformed to the
“Position of the American Heart Association on Research
Animal Use,” adopted by the Association in November 1984.
They were performed in eight adult mongrel dogs and 12
Sprague-Dawley rats. The dogs were used to assess temporal
changes in myocardial opacification after reflow from a single
injection of AIP 201 (Andaris Ltd.) administered during
coronary occlusion, with reference to changes in myocardial
blood flow (MBF). The rats were used to study the behavior of
AIP 201 in the microcirculation with intravital microscopy
(IM) both in the absence and presence of ultrasound. Finally,
in vitro experiments were performed to elucidate the physical
effects of ultrasound energy on the microbubbles.
Experimental preparations. Canine model. Dogs were
anesthetized with 30 mgzkg21 of sodium pentobarbital (Abbott
Laboratories), intubated and ventilated with room air by
means of a respirator pump (Model 607, Harvard Apparatus).
Additional anesthesia was administered during the experiment
as needed. A 7F catheter was placed in the femoral artery to
obtain pressure measurements and withdrawal of arterial
reference samples for radiolabeled microsphere MBF analysis.
A similar catheter was also placed in each femoral vein for
intravenous administration of fluids and drugs as needed. A
left lateral thoracotomy was performed, and the heart was
suspended in a pericardial cradle. The proximal portions of
either the left anterior descending coronary artery (LAD) or
left circumflex coronary artery (LCx) were dissected free from
the surrounding tissues, and an occluder was placed around
one of them. A 7F catheter was placed in the left atrium for
pressure measurement and injections of microbubbles and
radiolabeled microspheres.
Rat model. The Sprague-Dawley rats anesthetized with an
intramuscular injection of a mixture of 1% alpha-chloralose
and 13.3% urethane (0.6 mlz100g21 body weight) were placed
on a heating pad. The left femoral vein was cannulated for
administration of additional anesthesia as needed, and the
right carotid artery was similarly cannulated to enable micro-
bubble injection. The right spinotrapezius muscle was pre-
pared for IM as previously described (2,3). The 0.25-mm thick
muscle was exteriorized, leaving the anterior edge with the
main feeding artery and vein intact. It was continuously
superfused with warm (37°C) Ringer’s solution (pH 7.4)
saturated with 5% carbon dioxide and 95% nitrogen.
The preparation was moved to a custom-designed stage
with a water bath, which had a small aperture for placement of
the exteriorized muscle (Fig. 1). Its inside walls were lined with
baffled sponge rubber, which served as an ultrasound absorber.
The muscle was carefully drawn through the aperture into the
interior of the bath and spread over a transparent coverslip
placed on a hollow pedestal. A water-tight seal was created
between the margins of the aperture and the muscle using
nonreactive grease. The bath was then filled with warmed
Ringer’s solution, and the preparation was allowed a minimum
of 15 min to stabilize before observations were initiated.
Ultrasound imaging. Ultrasound examinations were per-
formed using a phased array system (HDI 3000cv, Advanced
Technology Laboratories) capable of harmonic imaging (trans-
mitted at 2.3 MHz and received at 4.6 MHz). Gain settings
were optimized at the beginning of each experiment and were
held constant throughout. A dynamic range of 60 dB and a
frame rate of 30 Hz were used. Images were recorded on
1.25-cm S-VHS videotape (Panasonic AG-MD830, Matsushita
Electric).
Canine experiments. A saline bath acted as an acoustic
interface between the transducer and the heart. The trans-
ducer was positioned over the heart by means of a clamp
affixed to the procedure table. A mechanical index (MI) of 0.7
to 0.9 was used. Short-axis images at the mid-papillary muscle
and the orthogonal long-axis levels were obtained. These
images were transferred from videotape to the video memory
of a computer where video intensity (VI) was measured from
regions of interest (.500 pixels) defined over the LAD and
LCx beds in both the long- and short-axis views. Measurements
Abbreviations and Acronyms
DTAF 5 5-([4,6-dichlorotriazin-2-YL] amino)-fluorescein hydrochloride
IM 5 intravital microscopy
LAD 5 left anterior descending coronary artery
LCx 5 left circumflex coronary artery
LV 5 left ventricular
MBF 5 myocardial blood flow
MCE 5 myocardial contrast echocardiography
MI 5 mechanical index
VI 5 video intensity
Figure 1. Preparation used for IM.
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from three consecutive end-diastolic frames were averaged for
each view from which the mean VI was calculated.
Rat experiments. The ultrasound transducer was positioned
in the water bath (Fig. 1). The image depth was set between 4
and 5.7 cm, and the muscle preparation was magnified using a
built-in zoom function. The MI was varied from 0.4 to 1.8.
In vitro experiments. A custom-designed stage was pre-
pared, and 10 ml of ultrasound gel was placed on one end of
the stage. The tip of the transducer was then placed in the gel
and positioned so the ultrasound beam could reach the micro-
bubbles under the coverslip on the slide mounted on the stage,
which could be observed on microscopy using a magnification
of 320.
Radiolabeled microsphere MBF measurement. Myocar-
dial blood flow was measured using left atrial injections of
;2z106 11-mm radiolabeled microspheres (Dupont Medical
Products) suspended in 4 ml of 0.9% saline and 0.01%
Tween-80 (4). Reference samples were withdrawn from the
femoral artery over 130 s with a constant rate withdrawal pump
(Model 944, Harvard Apparatus). At the end of the experi-
ment, the short-axis left ventricular (LV) slice corresponding
to the ultrasound image was cut into 16 wedge-shaped pieces,
and each piece was further divided into epicardial, mid-wall
and endocardial thirds. The tissue and reference blood samples
were counted in a well counter with a multichannel analyzer
(Model 1282, LKB Wallac). Corrections were made for activity
spilling from one energy window to another.
Myocardial blood flow to each epicardial, midcardial and
endocardial segment was calculated from the equation: Qm 5
(CmzQr)/Cr, where Qm is blood flow to the myocardial segment
(mlzmin21); Cm is tissue counts; Qr is the rate of arterial
sample withdrawal (mlzmin21); and Cr is arterial reference
sample counts (4). Transmural MBF (mlzmin21zg21) to each of
the 16 wedge-shaped pieces was calculated as the quotient of
the summed flows to the segments within that piece and their
combined weight. Myocardial blood flow to the LAD and LCx
beds was calculated by averaging MBF within the segments
representing the central 75% of each bed defined on MCE
during coronary occlusion.
Intravital microscopy. IM was performed using a Zeiss
customized microscope (ACM, Zeiss Inc.). Either a 320 or
363 water-immersion objective was used. Data were acquired
using a video camera (Model CCD-72, Dage-MTI Inc.)
mounted on the microscope and were recorded on videotape
using a S-VHS recorder (Model AG-1730, Matsushita). An
image intensifier (Genllsys, Dage-MTI Inc.) was used to
improve the signal-to-noise ratio, and the final output was
displayed on a high resolution monitor (Model PVM-137, Sony
Corp.).
Protocols. Canine experiments. Five minutes after coro-
nary occlusion, 10 to 15 ml (0.3 to 0.5 mlzkg21) of AIP 201 was
injected into the left atrium during simultaneous ultrasound
imaging (1), followed by injection of radiolabeled micro-
spheres. Coronary occlusion was maintained for ;0.5 to 3 h in
individual dogs, followed by up to 3 h of reperfusion. Imaging
was performed periodically during reperfusion, at which time
radiolabeled microspheres were also injected. Just before
termination of the experiment, a second dose of AIP 201 was
injected during simultaneous ultrasound imaging, followed by
the final injection of radiolabeled microspheres. At the end of
the experiment, the heart was excised for radiolabeled micro-
sphere MBF analysis.
Rat experiments. To facilitate their identification in the
microcirculation, microbubbles were labeled with fluorescein-
DTAF (Sigma Chemical) (5). Approximately 2 ml of AIP 201
was withdrawn from a vented vial into a syringe containing 0.5
to 1.0 mg of DTAF, which was then gently rotated to allow
mixing of the microbubbles and the DTAF. The solution was
then reinjected into the vented vial containing the remainder
of the microbubbles, and the vial was placed on a mechanical
roller for 10 min to ensure thorough mixing. In preliminary
studies, it was determined that a single dose of ;3z106 micro-
bubbles (0.2 ml) could be injected into the carotid artery
without compromising the microcirculation and also providing
reasonable opacification of the muscle on ultrasound exami-
nation.
In the first seven rats, microbubble behavior was studied
within the microcirculation without exposure to ultrasound.
Before their injection, the entire spinotrapezius muscle was
previewed. After carotid artery injection of AIP 201, imaging
was switched from transillumination to epi-illumination at a
peak wavelength of 510 nm, which is the excitation wavelength
for DTAF.
To simulate ischemia-reperfusion, the distal portion of the
main artery was occluded, followed by microbubble injection
and IM. Five to 35 min later, the occlusion was reversed and
the muscle was reexamined for up to 90 min. In two rats,
adenosine (1024 molar solution) was superfused on the muscle
during reperfusion. To study the effect of muscle contraction
on microbubble rheology, a pacemaker (Model 5320,
Medtronic) was attached to the muscle in one rat, and the
voltage was increased from 0.4 to 20.0 mA and the pacing rate
was increased from 50 to 150zmin21.
In the next seven rats, microbubble behavior within the
microcirculation was examined before and after the applica-
tion of ultrasound. The number of microbubbles lodged within
each field of view in the entire muscle was counted before and
30 to 80 min after ultrasound exposure using various MIs.
Statistical methods. Data are expressed as the mean value
6 SD. Repeated measures analysis of variance was used to
compare VI measurements during coronary occlusion and
reperfusion. Comparisons between MCE and radiolabeled
microsphere-derived MBF measurements were made using
linear regression analysis. Comparisons of paired and unpaired
data from IM experiments were performed using nonparamet-
ric tests (Wilcox and Mann-Whitney). Statistical significance
was defined as p , 0.05.
Results
Canine experiments. Of the eight dogs, one died immedi-
ately after reperfusion from ventricular fibrillation and was
1767JACC Vol. 32, No. 6 LINKA ET AL.
November 15, 1998:1765–72 SPONTANEOUS REDISTRIBUTION AFTER REPERFUSION
excluded from analysis. Figures 2 and 3 depict short- and
long-axis views from one of the remaining seven dogs that
underwent LAD occlusion. During coronary occlusion, a per-
fusion defect was seen after a single injection of AIP 201 (Fig.
2A and 3A). By the time this image was acquired (,1 min after
injection), all the bubbles had cleared from the LV cavity.
Despite the rapid clearance of microbubbles from the LV
cavity, it took at least 5 min to achieve maximal myocardial
opacification in the nonoccluded control bed. No further
change in VI was noted in either the occluded or the control
bed for up to 3 h of coronary occlusion.
A spontaneous increase in VI was noted in the LAD bed
10 min after reperfusion, even without a second injection of
microbubbles (Figs. 2B and 3B), and no recirculation was
noted in the LV cavity. This increase in VI was even greater
120 min later (Fig. 2C and 3C). When a second injection of
AIP 201 was performed, as expected, myocardial opacification
was greater in the entire myocardium (Fig. 2D and 3D).
However, the VI ratios between the reperfused and control
bed were not different from those observed just before the
second injection (Fig. 2C and 3C).
The temporal changes in MCE data are depicted in Figure
4. As would be expected, the VI in the occluded bed is less than
half of that in the nonoccluded bed. After reperfusion it
increases progressively over time and normalizes at a mean of
94 min, without a second injection of AIP 201. Video intensity
in the control bed remains stable over this same period. When
a second injection of AIP 201 is given just before termination
of the experiment, VI in both the beds increases, but the ratio
between the two beds does not change.
Figure 5 depicts the relation between radiolabeled
microsphere-derived MBF and VI ratios from the hypoper-
fused and control beds during coronary occlusion and at
various intervals after reperfusion after the first injection of
AIP 201. Data obtained after the second injection of AIP 201,
before termination of the experiment, are also depicted. There
is a linear relation indicating that the VI ratios between the two
beds reflect the MBF ratios between these beds.
Rat experiments. In the six rats undergoing ischemia-
reperfusion without ultrasound exposure, no microbubbles
were seen entering the muscle distal or proximal to the
occluder at any time after their injection. After reperfusion, no
bubbles were seen to enter the muscle during the 90-min
Figure 2. Short-axis views from a dog undergoing LAD occlusion (A)
and reperfusion (B to D). Images in panels A to C are obtained after
the first injection of AIP 201, and the image in panel D was obtained
after the second injection of AIP 201. The perfusion defect in panel A
is indicated by an arrow. Panels B and C were obtained 10 and 120 min
after reperfusion and show a progressive increase in VI in the LAD
bed. See text for details.
Figure 3. Long-axis views from the same dog whose images are
depicted in Figure 2. The timing of the images in panels A to D
correspond to the timing of similar images in Figure 2.
Figure 4. Changes in mean VI in the occluded and control beds in the
seven dogs analyzed. *Significant (p , 0.003) differences in VI. †No
differences in VI.
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observation period, even after arteriolar vasodilation with
adenosine.
In the six rats with data during ultrasound exposure,
microbubbles were seen to be entrapped within the microcir-
culation after their injection through the carotid artery. Most
of them were lodged as single bubbles in small arterioles
(#10 mm in diameter). Red blood cell flow and plasma flow
were usually absent in these vessels (Fig. 6A). Sometimes
trains of 2 to 20 bubbles could be seen within arterioles.
Aggregation or clusters of bubbles (4 or 5 to almost 100) could
also be found in arterioles ranging in size from 20 to 80 mm in
diameter (Fig. 6B). A smaller microbubble was occasionally
seen passing through a capillary.
The microbubble aggregates seen within the larger arte-
rioles were associated with different flow patterns. Sometimes
no flow was seen. At other times, temporary cessation of flow
was seen with periodic resumption of reduced flow around the
aggregates. At still other times, after a temporary reduction,
normal flow resumed around the aggregates. Each instance of
flow reduction was preceded by total or subtotal obstruction of
the arterioles. Similarly, flow resumption invariably occurred
after dilation of the arteriole at the site of obstruction, and the
dilation reversed when the aggregates moved downstream.
The aggregates themselves demonstrated changes in their
size and location, which were principally related to changes in
flow. When flow improved entire aggregates could become
dislodged from larger arterioles and move further downstream
to the smaller arterioles. At other times a few microbubbles
would separate from the aggregates and move downstream
before they became lodged in smaller arterioles (Fig. 7). These
aggregates could later become dislodged and reach even
smaller arterioles.
Muscle opacification was seen on ultrasound at the time of
appearance of the microbubbles within the microcirculation.
Figure 8 illustrates ultrasound images of the spinotrapezius
muscle from one rat before and after injection of micro-
bubbles. No bubble destruction was seen in vivo, even during
insonification at a maximal MI of 1.8. Before ultrasound
exposure, 2.2 6 1.5 bubbles per viewing field were noted and
2.1 6 1.5 were found after ultrasound exposure (p 5 NS). The
aggregation or disaggregation of microbubbles was also not
affected by ultrasound. Pacing induced muscle contraction but
did not affect microbubble lodging or behavior.
Figure 5. Relation between MBF ratio (x axis) and VI ratio (y axis)
between the hypoperfused and normal beds from all ultrasound and
radiolabeled microsphere measurements. Open and closed squares
represent data from coronary occlusion and a mean of 36 min after
reperfusion obtained after the first injection of AIP 201, whereas open
and closed circles represent data at a mean of 94 min and 100 min after
reperfusion obtained from the first and second AIP 201 injections,
respectively.
Figure 6. Entrapment of single microbubbles in
small arterioles (A) and microbubble aggregates in
larger arterioles (B). See text for details.
Figure 7. Lodging of microbubbles further downstream after dislodg-
ing from a more proximal site.
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In vitro experiments. When present in low concentrations,
microbubbles were slowly pushed away from the focal point of
the transducer on exposure to ultrasound. When present in
higher concentrations, with smaller distances between them,
microbubbles moved toward each other on exposure to ultra-
sound, and the movement accelerated as they approached one
another. This phenomenon led to the formation of aggregates
of varying sizes within seconds of ultrasound exposure (Fig.
9A). After ultrasound was discontinued, disintegration of these
aggregates was noted with individual microbubbles separating
from each other (Fig. 9B). Finally, similar to in vivo observa-
tions, no microbubble destruction was noted in vitro, even at
the maximal MI of 1.8.
Discussion
The main findings of this study are that 1) after a single
injection during coronary occlusion, AIP 201 microbubbles
spontaneously redistribute to the myocardium after reperfu-
sion; 2) the magnitude of redistribution is related to changes in
MBF to the reperfused myocardium; 3) the mechanism of
redistribution is probably related to dislodgement after reflow
of microbubbles from aggregates lodged in collateral arterioles
10 to 80 mm in size; and 4) the in vitro behavior of these
microbubbles is not replicated in the microcirculation. These
findings may have important implications for the assessment of
myocardial perfusion, particularly after interventions for acute
ischemic syndromes in the cardiac catheterization laboratory,
after revascularization following coronary artery bypass graft
surgery, and for the assessment of collateral vessel function.
Unique characteristics of AIP 201. Most preformed micro-
bubbles in commercially produced ultrasound contrast agents
are small enough to pass through the pulmonary microcircu-
lation and result in LV and myocardial opacification (6). A
small fraction that are larger than the pulmonary capillary
diameter are filtered by the lungs. Because they have already
passed through the lungs, the microbubbles reaching the left
heart can easily pass through the coronary circulation in a
manner similar to red blood cells (3). Assessing an intervention
aimed at altering MBF, however, requires repeated adminis-
tration of such agents.
AIP 201 is currently the only ultrasound contrast agent
containing preformed microbubbles that are similar to micro-
spheres, in that they become lodged in the myocardial micro-
circulation after a left heart injection. This finding was con-
firmed in this study in the experiments using IM. The mean
diameter of the bubbles is 10 6 0.4 mm, with 70% being .7 mm
and 0.5% being $20 mm. These bubbles contain room air and
are encapsulated in a 1-mm shell composed of denatured
albumin. Unlike other air-filled albumin microbubbles that
become smaller in size after contact with blood because of
outward diffusion of air (7), the thick shell of AIP 201
microbubbles prevents diffusion of gases and maintains their
size in vivo. These properties result in long-lasting myocardial
opacification on ultrasound examination after a left heart
injection. The large microbubble size, however, precludes the
use of this agent for venous administration.
Mechanism of redistribution. Redistribution is a phenom-
enon described with thallium-201 (8). It occurs from uptake of
the tracer from blood during repeated recirculation through
the coronary system. The redistribution seen with AIP 201
cannot be explained by this phenomenon because recirculation
is absent. Most microbubbles are entrapped in the coronary
circulation during their first pass, and the ones that do not get
Figure 8. Ultrasound images of the spinotrapezius muscle
before (A) and after (B) microbubble injection. The central
portion of the image represents the muscle. The spokelike
structures are sutures used to spread out the muscle.
Figure 9. In vitro aggregation of microbubbles sus-
pended in saline after ultrasound exposure (A) and
disaggregation after discontinuation of ultrasound
(B).
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entrapped are cleared from blood probably by entrapment in
other organs.
There are other possible mechanisms to explain this phe-
nomenon of redistribution. Because we noted this effect in a
beating canine heart, we wanted to exclude muscle contraction
as the cause of this phenomenon. Pacing of the rat spinotra-
pezius muscle did not result in any movement of the entrapped
microbubbles. Because redistribution in the canine experi-
ments could only be seen by performing an ultrasound exam-
ination, we also wanted to exclude the possible effect of
ultrasound on microbubble behavior. Microbubble behavior
was influenced by ultrasound in the in vitro experiments as a
result of radiation forces (9,10). These forces result from
positive (primary radiation effect) and negative (secondary
radiation effect) pressures around the microbubbles, which
cause them to move either outward or inward, respectively.
Microbubbles have to be physically unhindered for this phe-
nomenon to occur. It is probably for this reason that a similar
behavior was not observed in the microcirculation on exposure
to ultrasound. Entrapment in smaller arterioles and limited
mobility in larger arterioles prevent ultrasound-induced mo-
tion.
The only other putative mechanism for redistribution in-
volves lodging of microbubbles in larger arterioles that are not
present within the myocardium but are present on its epicar-
dial surface. After reperfusion, these microbubbles would then
migrate to the formerly occluded bed. Our results support this
mechanism. First we noted that opacification in the normal
myocardium increased gradually over at least 5 min after left
atrial injection, which was several minutes after the bubbles
had cleared from the LV cavity. These results imply that all
bubbles are not immediately deposited to even normally
perfused myocardium, but are gradullary transported there
from the coronary circulation proximal to the myocardium.
This notion was further supported by IM, where microbubbles
were seen as aggregates in larger arterioles from where they
periodically dislodged and moved more distally to smaller
arterioles.
Because the coronary artery was occluded, the only way in
which microbubbles could have reached arterioles distal to it is
through collateral vessels. The pressure difference between the
occluded and nonoccluded beds is maximal during coronary
occlusion, which would facilitate this phenomenon (11,12). It is
probable that the microbubbles were entrapped in the larger
epicardial collateral arterioles supplying the occluded bed and
became dislodged after resumption of flow to that bed. This
disaggregation of microbubbles takes several minutes to hours
depending on MBF to the heart muscle. Although the rat
spinotrapezius muscle is supplied by collateral vessels, any such
vessels are separated from the muscle during its isolation. The
absence of collateral vessels can explain the lack of redistribu-
tion to the spinotrapezius muscle after reflow, even during
adenosine exposure.
The mechanism of microbubble aggregation in vivo is not
clear. This phenomenon has also been described with micro-
spheres (4). Suspension in a Tween solution (polyoxyethylene
sorbitan mono-oleate), which acts as a surfactant, reduces the
aggregation of microspheres (4). The mechanism of micro-
bubble aggregation could be similar to that of microspheres.
Low doses of Tween are used while preparing these micro-
bubbles to reduce aggregation. Although higher doses may be
required to completely inhibit aggregation, they may result in
hemodynamic disturbances (13).
Clinical implications. Microbubbles are most likely to be
used in the echocardiography laboratory and the emergency
room for the detection of chronic coronary artery disease and
acute ischemic syndromes (7). In these situations, it is neces-
sary to use microbubbles that are capable of pulmonary transit
rather than those requiring a direct left heart injection. There
are situations, however, where access to the left heart has
already been obtained for other reasons, such as during cardiac
catheterization and open heart surgery. In these settings, a
direct injection of microbubbles into the left heart, aorta or
coronary arteries has previously provided useful information
(14–18). The advantage of AIP 201 over other contrast agents
is that it requires only a single injection before an intervention
such as primary angioplasty for acute myocardial infarction or
placement of coronary artery grafts. The microbubbles are
likely to become lodged in extramyocardial arterioles supplying
the occluded or poorly perfused bed, and then they embolize to
smaller myocardial arterioles when flow is restored. Thus, the
success of a revascularization procedure can be judged without
repeated injections of microbubbles. In addition, because of
the long-lasting myocardial opacification, the effect of the
intervention can also be monitored after the procedure—for
example, in the recovery room.
Because redistribution of these bubbles is not possible in
the absence of collateral vessels, myocardial opacification after
restoration of adequate flow also indicates collateral vessel
function (11,12). The effects of various pharmacologic agents
on collateral vessel function could be studied in humans, as
could the effect of growth factors that promote angiogenesis
(19,20). By acting as deposit tracers, these microbubbles also
reflect relative MBF and could be used to assess serial changes
in this measurement. These applications, however, need to be
verified in clinical studies.
Obstruction and plugging of microvessels have disadvan-
tages in that they can cause reductions in MBF. It has been
demonstrated that up to 22 million 7- to 10-mm sized radiola-
beled microspheres can be safely administered through the left
atrium at rest without any adverse hemodynamic effects (21).
Because only ;5% of total cardiac output is distributed to the
coronary circulation during rest, these results imply that ;1
million microbubbles can become lodged in the myocardium
without significant hemodynamic effects. These experiments
were performed in normal hearts (21). The number of micro-
bubbles that would be tolerated in situations where MBF is
compromised will be less depending on the microvascular state
of the myocardium. In a canine model of ischemia-reperfusion,
we have previously shown that at similar doses to those used in
this study, AIP 201 does not cause any hemodynamic changes,
despite the instability of the preparation (1). Similar results
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need to be demonstrated in humans before AIP 201 can be
recommended for clinical use.
We thank N. Craig Goodman, BS, Soroosh Firoozan, MD, and Gursel Ates, MD,
for assisting in the canine experiments.
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